1 Introduction The expanded clinical spectrum of autoantibody-associated neurological diseases has identified many potentially treatable, and therefore “not to miss,” clinical phenotypes [1-3]. The associated increase in indiscriminate testing has resulted in frequent detection of clinically irrelevant antibodies, representing the commonest precipitant of misdiagnosis and iatrogenic harm in this field [4-6].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Maya
Contact Maya, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack